{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:25:22Z","timestamp":1775129122930,"version":"3.50.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.ijcard.2007.04.172","type":"journal-article","created":{"date-parts":[[2007,8,9]],"date-time":"2007-08-09T11:38:50Z","timestamp":1186659530000},"page":"3-12","source":"Crossref","is-referenced-by-count":53,"title":["Postprandial lipemia: An under-recognized atherogenic factor in patients with diabetes mellitus"],"prefix":"10.1016","volume":"126","author":[{"given":"Socrates","family":"Pastromas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela-Beth","family":"Terzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Tousoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon","family":"Koulouris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2007.04.172_bib1","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0021-9150(97)00314-6","article-title":"Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance","volume":"137","author":"Lakkso","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2007.04.172_bib2","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes, 1995\u20132025: prevalence, numerical estimates, and projections","volume":"21","author":"King","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2007.04.172_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.59.1.8","article-title":"Diabetes and cardiovascular risk factors: the Framingham study","volume":"59","author":"Kannel","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00008","article-title":"Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention","volume":"1241","author":"Savage","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijcard.2007.04.172_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/dmr.5610030206","article-title":"Diabetes and atherosclerosis: an epidemiologic view","volume":"3","author":"Pyorala","year":"1987","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.ijcard.2007.04.172_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2007.04.172_bib7","series-title":"Diabetes in America","first-page":"1","article-title":"Mortality from diabetes","author":"Harris","year":"1985"},{"key":"10.1016\/j.ijcard.2007.04.172_bib8","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","article-title":"Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association","volume":"100","author":"Grundy","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2007.04.172_bib10","first-page":"V67","article-title":"Dysfunction of the vascular endothelium in diabetes mellitus","volume":"87","author":"Cohen","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","article-title":"Diabetic dyslipidaemia: from basic research to clinical practice","volume":"46","author":"Taskinen","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2007.04.172_bib12","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2337\/diacare.20.11.1683","article-title":"U.K. Prospective Diabetes Study 27: plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2007.04.172_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","article-title":"Atherogenesis: a postprandial phenomenon","volume":"60","author":"Zilversmit","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib14","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1161\/01.ATV.17.12.3542","article-title":"Lipoprotein heterogeneity and apolipoprotein B metabolism","volume":"17","author":"Packard","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2796.1999.00548.x","article-title":"Postprandial lipoprotein metabolism and atherosclerosis","volume":"246","author":"Karpe","year":"1999","journal-title":"J Int Med"},{"key":"10.1016\/j.ijcard.2007.04.172_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/dmr.5610030208","article-title":"Lipoprotein lipase in diabetes","volume":"3","author":"Taskinen","year":"1987","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.ijcard.2007.04.172_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-2275(20)33334-4","article-title":"Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulphate proteoglycans and apolipoprotein","volume":"40","author":"Mahley","year":"1999","journal-title":"Eur J Lipid Res"},{"issue":"Suppl 2","key":"10.1016\/j.ijcard.2007.04.172_bib18","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1055\/s-2001-18580","article-title":"Pathogenesis of dyslipidemia in type 2 diabetes","volume":"109","author":"Taskinen","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ijcard.2007.04.172_bib19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1172\/JCI111711","article-title":"Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.","volume":"75","author":"Wang","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijcard.2007.04.172_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2362.1996.114256.x","article-title":"Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis","volume":"26","author":"De Man","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ijcard.2007.04.172_bib21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jc.86.3.965","article-title":"Diabetic dyslipidemia: causes and consequences","volume":"86","author":"Goldberg","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijcard.2007.04.172_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0022-2275(20)41523-8","article-title":"Abnormalities of low density lipoproteins in normolipidemic type 2 diabetic and nondiabetic patients with coronary artery disease","volume":"33","author":"Tilly-Kiesi","year":"1992","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ijcard.2007.04.172_bib23","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1161\/01.ATV.17.11.2713","article-title":"Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians","volume":"17","author":"Gray","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF00400677","article-title":"Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides","volume":"39","author":"Lahdenpera","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2007.04.172_bib25","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/diacare.27.6.1496","article-title":"Lipids and lipoproteins in patients with type 2 diabetes","volume":"27","author":"Krauss","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2007.04.172_bib26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.CIR.92.3.364","article-title":"HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus","volume":"92","author":"Syv\u00e4nne","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib27","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1210\/jc.86.5.1962","article-title":"In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type 2 diabetes mellitus","volume":"86","author":"Frenais","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijcard.2007.04.172_bib28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1172\/JCI5286","article-title":"Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men","volume":"103","author":"Lamarche","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijcard.2007.04.172_bib29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.CIR.101.9.975","article-title":"Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state","volume":"101","author":"Haffner","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.ATV.15.3.320","article-title":"Relation between insulin resistance, hyperinsulinemia, post heparin plasma lipoprotein lipase activity and post-prandial lipemia","volume":"15","author":"Jeppesen","year":"1995","journal-title":"Arterioscl Thromb"},{"key":"10.1016\/j.ijcard.2007.04.172_bib31","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1161\/01.CIR.101.15.1773","article-title":"Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus","volume":"101","author":"Evans","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1365-2362.2001.00854.x","article-title":"Triglycerides and endothelial function in type 2 diabetes","volume":"31","author":"Rongen","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ijcard.2007.04.172_bib33","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.CIR.0000027569.76671.A8","article-title":"Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation","volume":"106","author":"Ceriello","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0021-9150(98)00170-1","article-title":"Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis","volume":"141","author":"Watts","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2007.04.172_bib35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0002-8703(86)90296-6","article-title":"The triglyceride issue: a view from Framingham","volume":"112","author":"Castelli","year":"1986","journal-title":"Am Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.ijcard.2007.04.172_bib36","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0021-9150(98)00219-6","article-title":"Triglycerides are more important in atherosclerosis than epidemiology has suggested","volume":"141","author":"Durrington","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2007.04.172_bib37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.ATV.11.3.653","article-title":"Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease","volume":"11","author":"Groot","year":"1991","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib38","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/01.ATV.12.11.1336","article-title":"The relationship of triglyceride metabolism and coronary artery disease: studies in the postprandial state","volume":"12","author":"Patsch","year":"1992","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies","volume":"3","author":"Hokanson","year":"1996","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.ijcard.2007.04.172_bib40","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jama.1996.03540110036029","article-title":"A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction","volume":"276","author":"Stampfer","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2007.04.172_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib42","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/01.ATV.15.11.1812","article-title":"Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins","volume":"15","author":"Abbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0021-9150(98)00170-1","article-title":"Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis","volume":"141","author":"Watts","year":"1998","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ijcard.2007.04.172_bib44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041433-199910000-00002","article-title":"Diabetic dyslipidaemia and coronary heart disease: new perspectives","volume":"10","author":"Evans","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib45","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1001\/jama.1997.03550200058032","article-title":"Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal","volume":"278","author":"Plotnick","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2007.04.172_bib46","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/01.CIR.88.4.1421","article-title":"Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes","volume":"88","author":"Laakso","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib47","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI115499","article-title":"Role of oxidized low-density lipoprotein in atherogenesis","volume":"88","author":"Wiztum","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijcard.2007.04.172_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1099-0895(199603)12:1<69::AID-DMR158>3.0.CO;2-B","article-title":"Modification of lipoproteins in diabetes","volume":"12","author":"Lopes-Virella","year":"1996","journal-title":"Diabetes\/Metab Rev"},{"key":"10.1016\/j.ijcard.2007.04.172_bib49","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1073\/pnas.90.14.6434","article-title":"Lipid advanced glycosylation: pathway for lipid oxidation in vivo","volume":"90","author":"Bucala","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijcard.2007.04.172_bib50","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2337\/diabetes.39.11.1420","article-title":"Autointoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose","volume":"39","author":"Hunt","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2007.04.172_bib51","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0006-291X(05)80875-7","article-title":"Free radicals generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes","volume":"173","author":"Mullarkey","year":"1990","journal-title":"Biochim Biophys Res Commun"},{"key":"10.1016\/j.ijcard.2007.04.172_bib52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib53","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.CIR.74.6.1399","article-title":"Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging","volume":"74","author":"Pignoli","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0021-9150(00)00499-8","article-title":"The relationships between postprandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes","volume":"154","author":"Anderson","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2007.04.172_bib55","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2337\/diacare.23.9.1401","article-title":"Association of postprandial hypertriglyceridemia and carotid intima media thickness in patients with type 2 diabetes","volume":"23","author":"Teno","year":"2000","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ijcard.2007.04.172_bib56","first-page":"386","article-title":"Plasma lipoproteins, hemostasis and thrombosis","volume":"86","author":"Griffin","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijcard.2007.04.172_bib57","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1161\/01.ATV.17.8.1539","article-title":"Coagulation factor VII and the risk of coronary heart disease in healthy men","volume":"17","author":"Junker","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0021-9150(90)90030-M","article-title":"Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids","volume":"80","author":"Marcman","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2007.04.172_bib59","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.ATV.16.11.1333","article-title":"In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway","volume":"16","author":"Silveira","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib60","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198512193132501","article-title":"Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction","volume":"313","author":"Hamsten","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2007.04.172_bib61","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0038-1657607","article-title":"PAI-1, obesity, insulin resistance and risk of cardiovascular events","volume":"78","author":"Juhan-Vague","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijcard.2007.04.172_bib62","first-page":"III-835","article-title":"Progression of PAI-1 levels in relation to incident type 2 diabetes","volume":"110","author":"Festa","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00041433-199906000-00007","article-title":"Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis","volume":"10","author":"Fruchart","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib64","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2007.04.172_bib65","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/diacare.29.s1.06.s4","article-title":"Standards of medical care in diabetes","volume":"29","author":"American Diabetes Association","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2007.04.172_bib66","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib67","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/ajcn\/76.5.1007","article-title":"Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension","volume":"76","author":"Woodman","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ijcard.2007.04.172_bib68","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1001\/archinte.158.22.2485","article-title":"Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in type II diabetes mellitus","volume":"18","author":"Emanuele","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2007.04.172_bib69","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2007.04.172_bib70","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1056-8727(97)00053-6","article-title":"Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus","volume":"12","author":"Palumbo","year":"1998","journal-title":"J. Diabetes Its Complicat."},{"key":"10.1016\/j.ijcard.2007.04.172_bib71","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-J\u00e4rvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2007.04.172_bib72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/0003-4819-134-1-200101020-00014","article-title":"Nonhypoglycemic effects of thiazolidinediones","volume":"134","author":"Parulkar","year":"2001","journal-title":"Ann Intern Med"},{"issue":"9493","key":"10.1016\/j.ijcard.2007.04.172_bib73","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"for the PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2007.04.172_bib74","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1161\/01.ATV.0000090521.25968.4D","article-title":"Thiazolidinediones and Blood Lipids in Type 2 Diabetes","volume":"23","author":"van Wijk","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1567-5688(01)00004-6","article-title":"Postprandial lipemia-effect of lipid-lowering drugs","author":"Karpe","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2007.04.172_bib76","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.CIR.0000027569.76671.A8","article-title":"Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation","volume":"106","author":"Ceriello","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib77","doi-asserted-by":"crossref","first-page":"77C","DOI":"10.1016\/j.amjcard.2005.12.014","article-title":"An assessment of statin safety by hepatologists","volume":"97","author":"Cohen","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib78","doi-asserted-by":"crossref","first-page":"6C","DOI":"10.1016\/j.amjcard.2005.12.006","article-title":"Statin safety: an overview and assessment of the data-2005","volume":"97","author":"Bays","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib79","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"for the CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicenter randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2007.04.172_bib80","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/diacare.20.4.614","article-title":"Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)","volume":"20","author":"Py\u00f6r\u00e4l\u00e4","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2007.04.172_bib81","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo controlled trial","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2007.04.172_bib82","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1161\/01.CIR.98.23.2513","article-title":"Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels. Subgroup analysis in the Cholesterol And Recurrent Events (CARE) trial","volume":"98","author":"Goldberg","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2007.04.172_bib83","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to prevet Heart Attack Trial (ALLHAT-LLT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2007.04.172_bib84","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0002-9149(02)02774-1","article-title":"Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia","volume":"90","author":"Gagne","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib85","first-page":"912","article-title":"Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease","volume":"81","author":"Fruchart","year":"1998","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.ijcard.2007.04.172_bib86","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00001573-200307000-00010","article-title":"Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome","volume":"18","author":"Cottrell","year":"2003","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib87","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(00)04209-4","article-title":"Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomized study","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2007.04.172_bib88","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"FIELD Study Investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2007.04.172_bib89","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group","volume":"341","author":"Rubins","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2007.04.172_bib90","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/diacare.25.7.1198","article-title":"Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia","author":"Athyros","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2007.04.172_bib91","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/eurheartj\/16.1.5","article-title":"Fibrates and statins in the treatment of hyperlipidemia: an appraisal of their efficacy and safety","volume":"16","author":"Shepherd","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2007.04.172_bib92","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00007611-199705000-00018","article-title":"Rhabdomyolisis associated with simvastatin\u2013gemfibrozil therapy","volume":"90","author":"Tal","year":"1997","journal-title":"Southern Med J"},{"key":"10.1016\/j.ijcard.2007.04.172_bib93","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0002-9149(99)00034-X","article-title":"Rhabdomyolysis and renal failure associated with cerivastatin\u2013gemfibrozil combination therapy","volume":"83","author":"Pogson","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib94","doi-asserted-by":"crossref","first-page":"50k","DOI":"10.1016\/S0002-9149(02)02970-3","article-title":"Combination therapy for dyslipidemia: safety and regulatory considerations","volume":"90","author":"Davidson","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib95","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11883-000-0093-1","article-title":"Mechanism of action of niacin on lipoprotein metabolism","volume":"2","author":"Kamanna","year":"2000","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ijcard.2007.04.172_bib96","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","article-title":"Clofibrate and niacin in coronary heart disease","volume":"231","year":"1975","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2007.04.172_bib97","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.amjcard.2004.09.013","article-title":"Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project)","volume":"95","author":"Canner","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2007.04.172_bib98","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.2165\/00003495-200565180-00014","article-title":"Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia","volume":"65","author":"McCormack","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2007.04.172_bib99","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ecl.2004.03.014","article-title":"Management of the metabolic syndrome-nicotinic acid","volume":"33","author":"Meyers","year":"2004","journal-title":"Endocrinol Metab Clin North Am"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527307010790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527307010790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T18:47:15Z","timestamp":1684003635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527307010790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0167527307010790"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2007.04.172","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}